CCL2 and pulmonary fibrosis: In the BLM-induced model of pulmonary fibrosis, inflammatory cytokines such as TNF-α increase immediately after BLM administration, and subsequently, levels of chemokines such as MCP-1, MIP-1α, and MIP-2 increase, resulting in the infiltration of inflamed cells into the lungs.